BACKGROUND: The purpose of this study was for us to determine National Comprehensive Cancer Network (NCCN) guideline-compliance of multidisciplinary conference (MDC) recommendations and actual treatment received, and to determine this impact on patient outcomes. METHODS: We conducted a retrospective review of patients presented at MDC between January 1, 2006, and December 31, 2006, with previously untreated incident cancers. RESULTS: We identified 232 patients, for whom MDC recommendations were NCCN guideline-compliant in 201 (86.6%). Actual treatment was NCCN guideline-compliant in 170 of 197 patients (86.3%). Adherence of MDC recommendations to NCCN guidelines was associated with superior overall survival (hazard ratio [HR] = 0.69; 95% confidence interval [CI] = 0.33-1.39; p = .3), as was guideline-compliance of actual treatment (HR = 0.6; 95% CI = 0.64-1.07; p = .07); congruence between MDC recommendations and actual treatment conferred a statistically significant overall survival benefit (HR = 0.49; 95% CI = 0.27-0.89; p = .02). CONCLUSION: Our findings argue for patient-centered application of NCCN guidelines. Prospective evaluation will enable more timely identification of systematic NCCN guideline deviations that quality improvement interventions may address.
BACKGROUND: The purpose of this study was for us to determine National Comprehensive Cancer Network (NCCN) guideline-compliance of multidisciplinary conference (MDC) recommendations and actual treatment received, and to determine this impact on patient outcomes. METHODS: We conducted a retrospective review of patients presented at MDC between January 1, 2006, and December 31, 2006, with previously untreated incident cancers. RESULTS: We identified 232 patients, for whom MDC recommendations were NCCN guideline-compliant in 201 (86.6%). Actual treatment was NCCN guideline-compliant in 170 of 197 patients (86.3%). Adherence of MDC recommendations to NCCN guidelines was associated with superior overall survival (hazard ratio [HR] = 0.69; 95% confidence interval [CI] = 0.33-1.39; p = .3), as was guideline-compliance of actual treatment (HR = 0.6; 95% CI = 0.64-1.07; p = .07); congruence between MDC recommendations and actual treatment conferred a statistically significant overall survival benefit (HR = 0.49; 95% CI = 0.27-0.89; p = .02). CONCLUSION: Our findings argue for patient-centered application of NCCN guidelines. Prospective evaluation will enable more timely identification of systematic NCCN guideline deviations that quality improvement interventions may address.
Keywords:
National Comprehensive Cancer Network (NCCN) guidelines; clinical practice guidelines; guideline compliance; head and neck cancer; quality improvement
Authors: Evan M Graboyes; Melanie E Townsend; Dorina Kallogjeri; Jay F Piccirillo; Brian Nussenbaum Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-12-01 Impact factor: 6.223
Authors: Evan M Graboyes; Elizabeth Garrett-Mayer; Mark A Ellis; Anand K Sharma; Amy E Wahlquist; Eric J Lentsch; Brian Nussenbaum; Terry A Day Journal: Cancer Date: 2017-08-25 Impact factor: 6.860
Authors: Tyler A Janz; Joanne Kim; Elizabeth G Hill; Katherine Sterba; Graham Warren; Anand K Sharma; Terry A Day; Chanita Hughes-Halbert; Evan M Graboyes Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-12-01 Impact factor: 6.223
Authors: Evan M Graboyes; Mark A Ellis; Hong Li; John M Kaczmar; Anand K Sharma; Eric J Lentsch; Terry A Day; Chanita Hughes Halbert Journal: Cancer Date: 2018-06-22 Impact factor: 6.860
Authors: Antoine Eskander; Axel Sahovaler; Jennifer Shin; Konrado Deutsch; Matthew Crowson; Neerav Goyal; David L Witsell; Kristine Schulz; Neil D Gross; Randal Weber; Samir S Khariwala; Seth Cohen; Derek Walter CyrLee; Vikas Mehta Journal: BMC Oral Health Date: 2021-05-17 Impact factor: 2.757
Authors: Harish Dharmarajan; Jennifer L Anderson; Seungwon Kim; Shaum Sridharan; Umamaheswar Duvvuri; Robert L Ferris; Mario G Solari; David A Clump; Heath D Skinner; James P Ohr; Dan P Zandberg; Barton Branstetter; Marion A Hughes; Katie S Traylor; Raja Seethala; Simion I Chiosea; Marci L Nilsen; Jonas T Johnson; Mark W Kubik Journal: Head Neck Date: 2020-04-27 Impact factor: 3.147